Solid lipid microparticles as a sustained release system for pulmonary drug delivery

被引:100
作者
Jaspart, Severine
Bertholet, Pascal
Piel, Geraldine
Dogne, Jean-Michel
Delattre, Luc
Evrard, Brigitte
机构
[1] Univ Liege, Lab Pharmaceut Technol, Dept Pharm, B-4000 Liege, Belgium
[2] Univ Liege, Natl & Synthet Drugs Res Ctr, Dept Pharm, B-4000 Liege, Belgium
关键词
solid lipid microparticles; pulmonary drug delivery; sustained release; salbutamol acetonide; experimental design;
D O I
10.1016/j.ejpb.2006.07.006
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The controlled release of drugs for pulmonary, delivery is a research field which has been so far rather unexploited but is currently becoming increasingly attractive. The introduction part of this research article first details the potential advantages of solid lipid microparticles (SLMs) as drug carrier compared to liposomes and polymeric microspheres. The aim of this work is to use SLMs to impart a sustained release profile to a model drug, salbutamol acetonide (SA). SA was synthesized from salbutamol in order to increase the lipophilicity of this molecule and thereby to increase its incorporation efficiency into SLMs. SA-loaded SLMs were then produced by a hot emulsion technique followed by high-shear homogenisation and the manufacturing parameters were optimized using the experimental design methodology in order to reach a suitable particle size for pulmonary administration. Scanning electron micrographs showed that SLMs are spherical, have a smooth surface and that SA crystallises outside of the particles when the drug loading is higher than 20%. This was confirmed by X-ray diffraction. SA in vitro release study from SLMs showed that the release rate increased with SA loading but remained in every case lower than the dissolution rate of pure SA. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:47 / 56
页数:10
相关论文
共 32 条
[1]   Poly-(D,L-lactic acid) microspheres incorporating histological dyes for intra-pulmonary histopathological investigations [J].
Armstrong, DJ ;
Elliott, PNC ;
Ford, JL ;
Gadsdon, D ;
Mccarthy, GP ;
Rostron, C ;
Worsley, MD .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1996, 48 (03) :258-262
[2]   Large porous particles for sustained protection from carbachol-induced bronchoconstriction in guinea pigs [J].
Ben-Jebria, A ;
Chen, DH ;
Eskew, ML ;
Vanbever, R ;
Langer, R ;
Edwards, DA .
PHARMACEUTICAL RESEARCH, 1999, 16 (04) :555-561
[3]   Influence of formulation excipients and physical characteristics of inhalation dry powders on their aerosolization performance [J].
Bosquillon, C ;
Lombry, C ;
Préat, V ;
Vanbever, R .
JOURNAL OF CONTROLLED RELEASE, 2001, 70 (03) :329-339
[4]   Resolution of albuterol acetonide [J].
Caira, MR ;
Hunter, R ;
Nassimbeni, LR ;
Stevens, AT .
TETRAHEDRON-ASYMMETRY, 1999, 10 (11) :2175-2189
[5]   Novel sustained release microspheres for pulmonary drug delivery [J].
Cook, RO ;
Pannu, RK ;
Kellaway, IW .
JOURNAL OF CONTROLLED RELEASE, 2005, 104 (01) :79-90
[6]   Production of lipospheres as carriers for bioactive compounds [J].
Cortesi, R ;
Esposito, E ;
Luca, G ;
Nastruzzi, C .
BIOMATERIALS, 2002, 23 (11) :2283-2294
[7]   Pulmonary drug delivery systems: Recent developments and prospects [J].
Courrier, HM ;
Butz, N ;
Vandamme, TF .
CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS, 2002, 19 (4-5) :425-498
[8]   Nebulisation of rehydrated freeze-dried beclomethasone dipropionate liposomes [J].
Darwis, Y ;
Kellaway, IW .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2001, 215 (1-2) :113-121
[9]   Large porous particles for pulmonary drug delivery [J].
Edwards, DA ;
Hanes, J ;
Caponetti, G ;
Hrkach, J ;
BenJebria, A ;
Eskew, ML ;
Mintzes, J ;
Deaver, D ;
Lotan, N ;
Langer, R .
SCIENCE, 1997, 276 (5320) :1868-1871
[10]   Poly(L-lactic acid) microspheres for pulmonary drug delivery: release kinetics and aerosolization studies [J].
El-Baseir, MM ;
Kellaway, IW .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1998, 175 (02) :135-145